European Commissioner for Health Stella Kyriakides (Francisco Seco/Pool via AP Images)
Europe buys 54,000 more doses of Bavarian Nordic's monkeypox vaccine as cases increase
The EU is back for more doses of monkeypox vaccines after seeing thousands of more cases.
The European Commission announced Monday that it reached a deal with Bavarian Nordic to buy an additional 54,000 doses of the biotech’s monkeypox vaccine after a substantial increase in monkeypox cases in the continent.
This order and others pushed Bavarian Nordic on Monday to also reup its 2022 revenue guidance, which is now expected to be between $368 million and $396 million (previously it was estimated to be between $314 million and $341 million).
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters